Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 26, Issue 3, Pages 187-192Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/14728222.2022.2040017
Keywords
Atypical teratoid rhabdoid tumor; ATRT; rhabdoid tumor; SWI; SNF; BAF; SMARCB1; epigenomics; enhancer; targeted therapeutics